During 2012, Pfizer supported Age Concern with the following:

Transcription

1 Action on Pain Action on Pain provides advice and support to people living with pain and strives to raise the profile of pain among politicians, the NHS and healthcare professionals. During 2012, Pfizer supported Action on Pain with the following: We made a donation in support of the organisation s mobile unit which promotes awareness and understanding of chronic pain. We arranged and paid one night s hotel accommodation for an Action on Pain staff member who was invited to attend a meeting about the Pfizer funded Can You Feel My Pain? campaign. o Hotel: ,137 0 Total: 3,137 As a guide this amount represents 13% of the total income of Action on Pain based on its last reported financial year (October September 2012). As part of the Pfizer-funded partnership campaign Can You Feel My Pain?, Pfizer created bespoke social media tools, such as the campaign s Facebook and Twitter pages, which we made available to Action on Pain as a partner in the campaign. Age Concern (Cowplain) Age Concern aims to improve later life for everyone through services and facilities for the wellbeing of older people in local areas. During 2012, Pfizer supported Age Concern with the following: Our Havant manufacturing site made a general donation from its Community Fund. 300 Total 300 As a guide this amount represents less than 1% of the total income of Age Concern based on its last reported financial year (July June 2011). Age UK Age UK aims to improve later life for everyone through information and advice, services, campaigns, products, training and research. During 2012, Pfizer contracted with Age UK on the following: We entered into a partnership working agreement to co-develop research about the experiences and expectations of older people and cancer. Age UK and Pfizer commissioned Picker Institute Europe to undertake the fieldwork. The fieldwork costs were funded by Pfizer. 70,000 Total: 70,000 As a guide this amount represents less than 1% of the total income of Age UK based on its last reported financial year (April March 2012).

2 Alzheimers Dementia Support Alzheimers Dementia Support is a charity which offers constructive practical guidance and a wide range of services to help people in the local community whose lives are directly or indirectly affected by Dementia. During 2012, Pfizer supported Alzheimers Dementia Support with the following: We made a donation to cover the cost of a support morning arranged by the organisation, including room hire and remuneration of therapists. 1,005 Total: 1,005 As a guide this amount represents 2% of the total income of Alzheimers Dementia Support based on its last reported financial year (June June 2012). Alzheimer s Society The Alzheimer's Society is a membership organisation which works to improve the quality of life of people affected by dementia in England, Wales and Northern Ireland. During 2012, Pfizer supported the Alzheimer s Society with the following: We arranged the donation of a speaker fee at the request of a speaker engaged by Pfizer. 500 Total: 500 As a guide this amount represents less than 1% of the total income of the Alzheimer s Society based on its last reported financial year (April March 2012). AntiCoagulation Europe AntiCoagulation Europe is a UK registered charity founded in the year AntiCoagulation Europe works with patients, healthcare professionals, NHS trusts, industry, governments, other charities and patient groups and a wide range of other organisations. Its aims are: the prevention of thrombosis; the provision of information, education and support; the promotion of independence - supporting people to take an active part in their own healthcare. During 2012, Pfizer supported AntiCoagulation Europe with the following: The BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited) made a donation towards the development cost of a guide to anticoagulation for patients. The BMS-Pfizer Alliance sponsored the Anticoagulation in Practice conference which was organised by AntiCoagulation Europe in association with The National Centre for Anticoagulation Training (NCAT) and University of Birmingham. 5,000* ( 2,000**) During 2012, Pfizer contracted the following services from AntiCoagulation Europe: The BMS-Pfizer Alliance paid a fee to AntiCoagulation Europe for consultancy on the development of a patient information booklet on atrial fibrillation. 250*

3 One AntiCoagulation Europe staff member featured in a BMS-Pfizer Alliance educational video on atrial fibrillation, for which a fee was paid. A consultancy fee was paid, at an agreed daily rate, for one AntiCoagulation Europe staff member to participate in a series of six planning meetings for an atrial fibrillation education and advocacy programme funded by the BMS-Pfizer Alliance The BMS-Pfizer Alliance paid for one staff member to travel to one of the above planning meetings from outside the UK. o Travel flight (value 82*) * 1,394* 0 Total: 6, As a guide this amount represents 5% of the total income of AntiCoagulation Europe based on its last reported financial year (January 2011 December 2011). We provided three delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 1,350). *Amounts shown are Pfizer s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases. **Payment made to Anticoagulation Europe, which acts as holding party for sponsorship payments for Anticoagulation in Practice. All sponsorship is then paid by Anticoagulation Europe to the National Centre for Anticoagulation Training. We have therefore not included this payment in the total figure of 6, given for payments from Pfizer to AntiCoagulation Europe. Anxiety UK Anxiety UK works to support people living with anxiety disorders by providing information, support and understanding through its range of services. During 2012, Pfizer supported Anxiety UK with the following: We made a donation to support expansion of the organisation's Destigmatise project to South Asian language speaking communities. 5,200 We made a donation to support the organisation s iphone application. 3,800 Total: 9,000 As a guide this amount represents 5% of the total income of Anxiety UK based on its last reported financial year (January December 2011). Anxiety UK partnered with Pfizer in the Let's Talk About GAD campaign, co-designing and utilising digital and print assets and participating in media opportunities. Arrhythmia Alliance Arrhythmia Alliance (A-A) is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. These groups remain independent, however, working together under the A-A umbrella to promote timely and effective diagnosis and treatment of arrhythmias.

4 During 2012, Pfizer supported the Arrhythmia Alliance with the following: The BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited) paid for a stand at the 2012 Heart Rhythm Congress, which is organised by the Arrhythmia Alliance. During 2012, Pfizer contracted the following services from the Arrhythmia Alliance: The BMS-Pfizer Alliance paid travel expenses for two Arrhythmia Alliance staff members to participate in a European atrial fibrillation patient advocacy meeting in Paris which was organised by the BMS- Pfizer Alliance. No consultancy fee was payable. o Travel flights (value - 1,023.20*) o Travel transfers (value *) o Accommodation (value - 180*) 1,925 0 Total: 1,925 As a guide this amount represents less than 1% of the total income of the Arrhythmia Alliance based on its last reported financial year (January 2011 December 2011). We provided four delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 1,800). *Amounts shown are Pfizer s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases. Arthritis Care Arthritis Care exists to support people with arthritis. Arthritis Care is the UK s largest charity working with and for all people who have arthritis. It is a user led charity which means people with arthritis are at the heart of all its work forming its membership, influencing and engaging in all of its activities and directing strategy by electing the board of trustees, the majority of whom are themselves people with arthritis. During 2012, Pfizer supported Arthritis Care with the following: We sponsored an Arthritis Care NI Meeting. 650 We sponsored an Arthritis Care NI Meeting. 499 We paid two night s hotel accommodation for an Arthritis Care staff 0 member who was invited to attend a meeting about the Pfizer-funded Can You Feel My Pain? campaign. o Hotel (value 273) During 2012, Pfizer contracted the following services from Arthritis Care: We paid a consultancy fee for two Arthritis Care staff members to participate in an advisory board on shared decision making. 800 Total: 1949 As a guide this amount represents less than 1% of the total income of Arthritis Care based on its last reported financial year (January 2011 December 2011). During 2012, Pfizer also provided in-kind support to Arthritis Care in the following ways: As part of the Pfizer-funded partnership campaign Can You Feel My Pain? Pfizer created bespoke social media tools, such as the campaign s Facebook and Twitter pages, which we made available to Arthritis Care as a supporter of the campaign.

5 Arthritis and Musculoskeletal Alliance (ARMA) ARMA is the umbrella body providing a collective voice for the arthritis and musculoskeletal community in the UK. Together, ARMA and its member organisations work to improve the quality of life for more than 10 million people in the UK with these conditions. ARMA has 40 member organisations representing a broad range of interests across service user, professional and research groups working in the field of musculoskeletal disorders. During 2012 Pfizer supported ARMA with the following: We paid for corporate membership of ARMA for ,000 Total 5,000 As a guide this amount represents 4% of the total income of ARMA based on its last reported financial year (January 2011 December 2011). ASH Wales ASH Wales is the leading voluntary organisation in Wales tackling tobacco use. Their main aim is to achieve a reduction in and eventual elimination of the health problems associated with tobacco use. During 2012 Pfizer supported ASH Wales with the following: We made a donation to the Wales Tobacco or Health programme through the corporate sponsorship scheme. We supported a Pfizer led symposium at the ASH Wales 2012 Conference 12,000 1,000 Total 13,000 As a guide this amount represents 3% of the total income of ASH Wales based on its last reported financial year (April 2011 March 2012). Asthma UK Asthma UK is the charity dedicated to improving the health and wellbeing of the 5.4 million people in the UK whose lives are affected by asthma. During 2012 Pfizer provided Asthma UK with in-kind support in the following ways: Two delegate space on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community. (Estimated value 900) Atrial Fibrillation Association (AF Association) The AF Association is an international charity which provides information, support and access to established, new or innovative treatments for atrial fibrillation (AF). During 2012, Pfizer supported the AF Association with the following: The BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited) made a donation towards the development and production costs of a GP revalidation toolkit produced by the Atrial Fibrillation Association. 12,500*

6 The BMS-Pfizer Alliance provided funding to enable the Atrial Fibrillation Association to provide the Secretariat to the All-Party Parliamentary Group on Atrial Fibrillation. The BMS-Pfizer Alliance provided funding towards the development of the Grasp the Initiative report, which was initiated by the AF Association and the BMS-Pfizer Alliance. 17,500* 12,500* During 2012, Pfizer contracted the following services from the AF Association: Two AF Association staff members participated in a European atrial fibrillation patient advocacy meeting which was organised by the BMS- Pfizer Alliance. An honorarium was paid for participation of one member of staff who chaired the meeting. The BMS-Pfizer Alliance paid travel expenses for the two staff members to travel to the above meeting and stay overnight in a hotel: o Travel flights (value - 877*) o Travel transfers (value *) o Accommodation (value - 180*) The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance European Advisory Board meeting. The BMS-Pfizer Alliance paid travel expenses for the staff member to attend the above meeting: o Travel Eurostar (value / 224*) o Travel transfers (value *) The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance European Advisory Board meeting. The BMS-Pfizer Alliance paid travel expenses for the staff member to attend the above meeting: o Travel flight (value *) o Travel transfers (value *) A consultancy fee was paid, at an agreed daily rate, for one staff member to participate in a series of six planning meetings for an atrial fibrillation education and advocacy programme funded by the BMS- Pfizer Alliance. One AF Association staff member featured in a BMS-Pfizer Alliance educational video on atrial fibrillation, for which a fee was paid. One AF Association staff member participated in an Advisory Board regarding patient insight research, which was funded by the BMS- Pfizer Alliance. The BMS-Pfizer Alliance paid a fee to the AF Association for consultancy on the development of a patient information booklet on atrial fibrillation. 750* 0 664* 0 532* 0 1,349* * 150* 250* Total: 46,464.50* As a guide this amount represents 15% of the total income of the AF Association based on its last reported financial year (January 2011 December 2011). NB. This percentage reflects the fact that the AFA is a relatively new organisation which is working to further develop diversified income streams. We donated the time of the BMS-Pfizer public affairs agency to assist the AFA with the development of the Grasp the Initiative report, which was initiated by the AF Association and the BMS-Pfizer Alliance (estimated value 7,500*). We donated the time of the BMS-Pfizer communications agency for two communications skills sessions for the AF Association (estimated value 8,000*).

7 We donated the time of the BMS-Pfizer communications agency to assist with the filming of AF patients for use in AF Association activities (estimated value 750). We provided two delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 900). *Amounts shown are Pfizer s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases. BackCare BackCare, the charity for healthier backs, is the only charity in the UK totally dedicated to providing support for, and campaigning on behalf of, people whose lives are significantly affected by back pain. During 2012, Pfizer supported BackCare with the following: We made a donation in support of the organisation's awareness week. 15,000 During 2012, Pfizer contracted the following services from BackCare: Honoraria for participation of a BackCare staff member in an educational meeting for healthcare professionals. 500 Total: 15,500 As a guide this amount represents 3% of the total income of BackCare based on its last reported financial year (January December 2011). As part of the Pfizer-funded partnership campaign Can You Feel My Pain?, Pfizer created bespoke social media tools, such as the campaign s Facebook and Twitter pages, which we made available to BackCare as a partner in the campaign. Beating Bowel Cancer Beating Bowel Cancer works to save lives by raising awareness of symptoms promoting early diagnosis and helping to improve access to treatment for people affected by this cancer. During 2012, Pfizer supported Beating Bowel Cancer with the following: We provided sponsorship for the organisation's patient day. 2,000 Total: 2,000 As a guide this amount represents less than 1% of the total income of Beating Bowel Cancer based on its last reported financial year (April March 2012). Bluebell Bluebell is a charity based in Bristol that supports mums, dads and families who are affected by antenatal or post-natal depression. During 2012, Pfizer provided in-kind support in the following way: One delegate space on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450).

8 British Dupuytren's Society British Dupuytren s Society (BDS) provides information and support to people affected by Dupuytren s Contracture, Ledderhose Disease and related conditions. In 2012, Pfizer provided in-kind support in the following ways: We donated 20 pairs of gloves that simulate Dupuytren s Contracture. (Estimated value 120) One delegate space on a Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450). British Lung Foundation Scotland & Northern Ireland The British Lung Foundation (BLF) Scotland & Northern Ireland exists to help people with lung disease. It does this by offering hope and support, promoting greater understanding of lung disease and campaigning for positive change in Scotland s lung health. During 2012, Pfizer provided BLF Scotland with in-kind support in the following way: BLF Scotland & NI partnered with Pfizer at the Scottish launch of a Pfizer commissioned report entitled Evaluating smoking cessation policy and practice in the UK. The event was held at the Scottish Parliament in September 2012 and a member of BLF Scotland & NI staff presented at the event. The British Liver Trust The British Liver Trust is the leading liver charity in the UK for all adult liver conditions. The Trust works to pioneer liver health and reduce the impact of liver disease through awareness, care and research. During 2012, Pfizer provided in-kind support in the following ways One delegate space on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450). Cancer52 Cancer52 is an alliance of more than 60 organisations working to address the inequalities that exist in policy, services and research into the less common cancers and to improve outcomes for patients with these highly challenging diseases. During 2012, Pfizer supported Cancer52 with the following: We provided corporate sponsorship of Cancer52 for ,000 Total: 8,000 As a guide this amount represents 22.2% of the total income of Cancer52 based on its last financial year (April 2011 April 2012). NB. This percentage reflects the fact that Cancer52 is an umbrella group of patient organisations, and therefore has limited potential to raise funds from diversified sources. Cancer Campaigning Group (CCG) The Cancer Campaigning Group (CCG) is an independent coalition of more than 50 national cancer charities representing service providers, research, advocacy and campaigning groups for cancer patients and its

9 families. The CCG s aim is to improve cancer policy and services across the six areas of public health and prevention, early diagnosis, treatment, survivorship, commissioning and research. During 2012, Pfizer supported the Cancer Campaigning Group with the following: We supported the costs associated with the running of the Cancer Campaigning Group. The CCG s planning is managed by a steering group of six elected cancer charities with the secretariat provided by MHP Communications. As a supporter, Pfizer meets regularly with the steering group to discuss emerging plans. 15,000 Total: 15,000 As a guide this amount represents 17% of the total income of the Cancer Campaigning Group based on its last financial year (January 2012 December 2012). NB. This percentage reflects the fact that the Cancer Campaigning Group is an umbrella group of patient organisations, and therefore has limited potential to raise funds from diversified sources. Cancer Focus Northern Ireland (Formerly Ulster Cancer Foundation) Cancer Focus Northern Ireland is a charity dedicated to helping patients and their families cope with cancer. Their mission is to save lives and to provide an enhanced quality of life for those affected by cancer through their care and support services, cancer research, cancer education and prevention programmes, public campaigns, lobbying and advocacy. During 2012 Pfizer supported Cancer Focus NI with the following: We provided funding to support a 2-day educational event entitled No Smoking Day in November Pfizer had a display stand at the meeting. We provided funding to support a 2-day educational event entitled No Smoking Day in November Pfizer had a display stand at the meeting. We made a donation to enable a member of staff to attend the UK National Smoking Cessation Conference 2011 meeting. 2,000 3, Total 5,400 As a guide this amount represents less than 1% of the total income of Cancer Focus NI based on its last reported financial year (August 2011 July 2012). Cancer Research UK Cancer Research UK is the world s leading cancer charity dedicated to saving lives through research. Together with their partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured. During 2012, Pfizer supported CRUK with the following: In 2011, we entered into a major 2m research partnership with CRUK 500,000 and other partners. The Stratified Medicine Programme is 5.5million partnership between CRUK, AstraZeneca, Pfizer and the government s Technology Strategy Board to propel forward the use of personalised cancer treatment. This was a balance payment as 1.5m was disclosed in our 2010/11 records. We partnered with the clinical development programme at CRUK s 32,000

10 Drug Development Office for work on a Pfizer medicine in its early development phase. We sponsored the NCRI Cancer Conference, which is administered by CRUK, a founding member. 25,000 Pfizer also contracted the following services from CRUK: A CRUK staff member participated in an advisory board about the lung cancer diagnostic environment in the UK. 750 Total: 557,750 As a guide this amount represents less than 1% of the total income of CRUK based on its last reported financial year (April March 2012). CHILDREN with CANCER UK CHILDREN with CANCER UK is a national children's charity dedicated to the fight against all childhood cancers. Pfizer provided in-kind support in the following ways: One delegate space on a Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450). Chronic Myeloid Leukaemia Support Group (The CML Support Group) The CML Support Group is the UK s only charity focusing exclusively on people diagnosed with Ph+ Chronic Myeloid Leukaemia. The CML Support Group website was set up in 2000 in order to reach out to all patients diagnosed with CML and to provide support, advice and information to them and their families. During 2012, Pfizer supported the Chronic Myeloid Leukaemia Support Group with the following: We made a donation towards the cost of CML Support s Stakeholder Outreach Programme. We made a donation towards development of the CML Support Group s website. During 2012, Pfizer contracted the following services from the Chronic Myeloid Leukaemia Support Group: We paid CML Support for consultancy on the development of a Pfizer CML patient survey. 8,000 1,000 1,000 Total 10,000 As a guide this amount represents 32% of the total income of the Chronic Myeloid Leukaemia Support Group based on its last reported financial year (January 2011 December 2011). NB. This percentage reflects the fact that the CML Support Group is a very small organisation focused on a rare disease type, and therefore has limited potential to raise funds from diversified sources. Cystitis and Overactive Bladder Foundation The Cystitis and Overactive Bladder Foundation provides information and support to sufferers of bladder problems, including Interstitial Cystitis, Bacterial Cystitis, Overactive Bladder and Urge Incontinence.

11 During 2012, Pfizer supported the Cystitis and Overactive Bladder Foundation with the following: We made a donation to enable the organisation to provide a Patient educational workshop day in the field of Cystitis & Overactive Bladder. We arranged and paid one night s hotel accommodation for a staff member from the organisation to attend a meeting about the Pfizerfunded Can You Feel My Pain? campaign. o Hotel (value - 179) We supported the Cystitis & Overactive Bladder Foundation through their corporate sponsorship programme. 1, During 2012 Pfizer contracted the following services from COB Foundation: Cystitis and Overactive Bladder Foundation provided consultancy on a disease awareness video. 500 Total 2,798 As a guide this amount represents 5% of the total income of the Cystitis and Overactive Bladder Foundation based on its last reported financial year (August 2011 July 2012). As part of the Pfizer-funded partnership campaign Can You Feel My Pain?, Pfizer created bespoke social media tools, such as the campaign s Facebook and Twitter pages, which we made available to Action on Pain as a supporter in the campaign. One delegate space on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450). Diabetes UK Diabetes UK provides practical support and information to help people manage their diabetes. The organisation campaigns for better standards of care and funds research into better treatments for diabetes. Through these types of activities Diabetes UK aims to improve the lives of people with diabetes. During 2012, Pfizer supported Diabetes UK with the following: We paid to display a stand at the Diabetes UK Putting Feet First meeting held in Portsmouth in April We paid to display a stand at a Diabetes UK meeting held in Solihull in July We paid to display two stands at Diabetes UK (NI) Diabetes Foot Conference held in Cookstown, Northern Ireland (2011 activity paid in 2012) During 2012 Pfizer contracted the following services from Diabetes UK: Diabetes UK provided consultancy on, and was a partner of, Pfizer s Man MOT project during ,600 Total 6,700 As a guide this amount represents less than 1% of the total income of Diabetes UK based on its last reported financial year (January 2012 December 2012). Education for Health

12 Education for Health aims to improve the outcomes for people living with long term conditions by educating the health professionals responsible for their care. Education for Health provides continuous professional education. Research is used to generate high quality publications which are used to drive up standards and improve patient care. During 2012 Pfizer supported Education for Health with the following: We provided a donation for the update & reprint of 1000 copies of 'Simply smoking cessation' book. We paid to display a stand at the Annual Update Meeting held in Warwick in October Sum received by the charity 4, Total 4,500 As a guide this amount represents less than 1% of the total income of Education for Health based on its last reported financial year (January 2011 December 2011). Epilepsy Society Epilepsy Society is a national epilepsy medical charity working for everyone affected by epilepsy, through cutting edge research, awareness campaigns and expert care. During 2012, Pfizer supported Epilepsy Society with the following: Donation to Epilepsy Society to update and print their patient information leaflet "pregnancy and parenting" 3,000 Total 3,000 As a guide this amount represents less than 1% of the total income of Epilepsy Society based on its last reported financial year (April 2011 March 2012). Pfizer provided in-kind support in the following ways: One pack of each of our medicines used for epilepsy was sent to the chief pharmacist at the Epilepsy Society to be photographed for inclusion in their guide to epilepsy medicines booklets, Pill booklet, (value ). Family Planning Association Sexual health charity Family Planning Association (FPA) works to establish a society in which everyone has positive, informed and non-judgmental attitudes to sex and relationships; where everyone can make informed choices about sex, relationships and reproduction so that they can enjoy sexual health free from prejudice or harm. During 2012 Pfizer contracted the following services from FPA: FPA provided consultancy on, and was a partner of, Pfizer s Man MOT project during FPA provided consultancy on, and was a partner of, Pfizer s Man MOT project January - May An FPA member of staff participated in an advisory board relating to the launch of a new contraceptive product. 5,000 2, Total 7,300 As a guide this amount represents less than 1% of the total income of the Family Planning Association based on its last reported financial year (April 2011 March 2012).

13 The Fungal Research Charitable Trust The Fungal Research Charitable Trust s aims are to: Advance education particularly amongst physicians and scientists about mycology, fungal diseases, fungal toxicology and microbial disease in general. Promote and publish research in all aspects of mycology, fungal diseases, fungal toxicology and microbial disease (of all living things). Generally support basic research into fungi and fungal disease, train scientists in mycology and related disciplines. During 2012, Pfizer supported The Fungal Research Charitable Trust with the following: Funding to support the development and maintenance of the Aspergillus website. Sponsorship of the Advances in Aspergillosis meeting 26th-28th Jan 2012, Istanbul. 25,000 45,110 Total 70,110 As a guide this amount represents 36% of The Fungal Research Charitable Trust s total income based on its last financial year (April March 2012). NB. This percentage reflects the fact that we sponsored a bi-annual international conference. Genetic Alliance UK Genetic Alliance UK aims to improve the lives of people affected by genetic conditions by ensuring that high quality services and information are available to all that need them. During 2012, Pfizer supported Genetic Alliance UK with the following We made a donation to support the delivery of the organisation s 'navigating the maze' project. We paid for one year corporate membership of the Genetic Alliance UK rare disease industry group Rare Diseases UK. We paid for a further two years corporate membership of the Genetic Alliance UK Rare Disease industry group Rare Diseases UK. We made a donation to support the delivery of consultation sessions with RDUK members. We made a donation to support the second phase of the risks and benefits project to examine how patients and their families with serious medical conditions perceive the risks and benefits of new therapies 53, ,750 17,000 2,750 15,000 During 2012, Pfizer contracted the following services from Genetic Alliance UK: We paid Genetic Alliance UK to write an article on rare disease for the Pfizer Life website 500 Total 96,522 As a guide this amount represents 12%* of Genetic Alliance UK s total income based on its last financial year (April March 2012). *This percentage reflects the fact that the first two payments listed were belated payments from These were mistakenly disclosed in our 2011 disclosure statement but the actual payments were made in Pfizer provided in-kind support in the following ways:

14 Two delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 900). GIST Support UK GIST Support UK provides information, support and education for patients with Gastro-Intestinal Stromal Tumours (GIST), a rare form of cancer. The charity also supports its carers and works closely with healthcare professionals to support research into GIST, and promote awareness, better diagnosis and treatment of GIST. During 2012, Pfizer supported GIST Support UK with the following: We sponsored a GIST Support UK patient day meeting. 3,000 We made a donation to support the development of GIST Support 2,000 UK's patient information, including printed material and the delivery of information via the GIST Support UK website. Total: 5,000 As a guide this amount represents 7% of the total income of GIST Support UK based on its last reported financial year (January 2011 December 2011). We provided four delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 1,800). The Haemophilia Society The Haemophilia Society is the only national and independent organisation for all people affected by bleeding disorders. The Society is led by affected people and works in close partnership with the NHS. It provides information and support for all people affected by bleeding disorder and represent their interests. During 2012, Pfizer supported the Haemophilia Society with the following: We made a donation to support a reception at the Scottish Parliament to raise the profile of haemophilia in Scotland and promote the need for good quality service provision. We made a 1 donation for each subscription to the Go Factor patient programme via the Haemophilia Society. We made a donation to support the development of a viable framework and management structure to expand the local groups and volunteering network. We made a donation to enable a Haemophilia Society staff member to attend the WFH conference to support the UK bid to hold conference in We made a donation to support the development and delivery of training for patient auditors. 5, , ,500 During 2012, Pfizer contracted the following services from the Haemophilia Society: A staff member from the organisation delivered a talk at a Pfizer organised workshop as part of the thinkspace programme. 350 Total 32,659 As a guide this amount represents 5% of the total income of The Haemophilia Society based on its last reported financial year (April 2011 March 2012).

15 Pfizer provided in-kind support in the following ways Provision of 100 Pfizer produced booklets entitled "Living with haemophilia B" to the Haemophilia Society for inclusion in their patient materials packs (estimated cost 200). Provision of printed materials and CDs from the Go Factor patient programme for use with patients (estimated cost 350). Heart of Mersey Heart of Mersey s vision is for Cheshire and Merseyside to be free from premature cardiovascular disease (CVD) death, brought about by associated lifestyle factors. They aim to undertake and promote action that leads to CVD prevention in, but not limited to, Cheshire and Merseyside. They use a population-based approach; advocating for policy and legislative change to influence lifestyle behaviours. This will happen through the creation of healthier environments that encourage healthy lifestyles as the norm rather than the exception. During 2012 Pfizer supported Heart of Mersey with the following: We supported a project to provide a brief intervention training programme for stewards at two sports stadia, Lancashire County Cricket Club & St Helens Rugby Club. We made a donation in support of a pilot smoking cessation brief intervention training programme to increase awareness among smokers with COPD of the availability of stop smoking support both in secondary and primary care. 15,000 15,000 Total 30,000 As a guide this amount represents 3% of the total income of Heart of Mersey based on its last reported financial year (April 2011 March 2012). HEART UK The Cholesterol Charity HEART UK supports those at risk of premature cardiovascular disease (CVD) due to raised cholesterol, especially those with inherited high cholesterol. The charity provides information to patients and their families, campaigns for better detection of CVD risk factors and supports research and health professional training. Through these types of activities, HEART UK strives to prevent premature deaths associated with high cholesterol and CVD. During 2012 Pfizer contracted the following services from HEART UK HEART UK provided consultancy on, and was a partner of, Pfizer s Man MOT project during HEART UK provided consultancy on, and was a partner of, Pfizer s Man MOT project during January May ,000 1,000 Total 11,000 As a guide this amount represents less than 1% of the total income of HEART UK based on its last reported financial year (March 2011 February 2012). HEART UK was a partner of the Pfizer-funded Real Danger patient safety campaign. Its logo was featured on campaign materials. Independent Cancer Patients Voice

16 Independent Cancer Patients Voice (ICPV) equips cancer patients to inform developments in medical research in the UK to ensure it is led by patients. Through bespoke training of patients as advocates, they are able to bring the opinions, views and experience of cancer patients, their families and carers, to the cancer research community. During 2012, Pfizer supported ICPV with the following: We made a donation towards the cost of ICPV s autumn residential meeting to train lay people to act as advocates for patients on issues related to cancer research. 3,000 Total: 3,000 As a guide this amount represents 43% of the total income of ICPV based on its last reported financial year (January 2011 December 2011). NB. This percentage reflects the fact that the ICPV is a relatively new, grassroots organisation that is still developing its income diversity. Two delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 900). International Glaucoma Association (IGA) The IGA is a patient-based organisation which works to prevent glaucoma blindness by providing information, literature, advice and support to thousands of Glaucoma sufferers. During 2012 Pfizer supported IGA with the following: We made a contribution towards the UK Paediatric Glaucoma Society Annual Meeting. 1,000 Total 1,000 As a guide this amount represents less than 1% of the total income of IGA based on its last reported financial year (August 2011 July 2012). Pfizer also provided IGA with in-kind support in the following ways: Two delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 900). James Whale Fund for Kidney Cancer James Whale Fund for Kidney Cancer (JWF) is a specialist kidney cancer charity. It seeks to help reduce the harm caused by kidney cancer by increasing knowledge and awareness, providing patient information and by supporting research into the causes, prevention and treatment of the disease. During 2012, Pfizer supported JWF with the following: We made a donation towards running patient and carer information days; a nurse education day and a symposium at BAUN. We made a further donation towards the patient support programme following increased demand for services and materials. Pfizer also contracted the following services from JWF : A staff member took part in Pfizer s Global kidney cancer advocacy meeting. No consultancy fee was payable, but Pfizer paid travel 9,600 2,000 0

17 expenses for the staff member to travel to the meeting and stay overnight in a hotel: o Flight - (value 129) o Transfers - (value 132) o Hotel - (value 170) Total: 11,600 As a guide this amount represents 4% of the total income of JWF based on its last reported financial year (October 2010 September 2011). Pfizer also provided in-kind support in the following way: Two delegate spaces on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 900). Jennifer Trust for Spinal Muscular Atrophy The Jennifer Trust for Spinal Muscular Atrophy informs, supports and empowers families and individuals affected by all forms of SMA and raises awareness of the condition. It also funds and supports the research community addressing the causes, treatment and management of Spinal Muscular Atrophy During 2011, Pfizer supported the Jennifer Trust for Spinal Muscular Atrophy with the following: We made a donation to support the general purposes and work of the Jennifer Trust for Spinal Muscular Atrophy. 25,000 Total: 25,000 As a guide this amount represents 4% of the total income of the Jennifer Trust for Spinal Muscular Atrophy based on its last reported financial year (April March 2012). Kidney Alliance The Kidney Alliance (KA) is an umbrella organisation formed in 1998 by the NKF, The British Renal Society and the Renal Association with an aim to bring together the patients voice and professionals committed to kidney care. During 2011, Pfizer supported the Kidney Alliance with the following: We made a donation to support disease awareness activities linked to World Kidney Day. 3,000 Total: 3,000 As a guide this amount represents 4% of the total income of the Kidney Alliance based on its last reported financial year (April 2011 March 2012). Leukaemia CARE Leukaemia CARE exists to provide vital care and support to all those whose lives have been affected by leukaemia, lymphoma, myeloma and the allied blood disorders. During 2012, Pfizer supported Leukaemia CARE with the following: We made a donation towards the cost of Leukaemia CARE s patient information materials and provision of patient support services. 5,000

18 During 2012, Pfizer contracted the following services from Leukaemia CARE: A staff member took part in Pfizer s Global Haematology Patient Advisory Board meeting. No consultancy fee was payable, but Pfizer paid for the staff member to travel to the meeting and stay overnight in a hotel. o Flight (value - $3, ( 2,371.22)) o Transfers (value - $ ( )) o Hotel (value - $1, ( )) 0 Total: 5,000 As a guide this amount represents less than 1% of the total income of Leukaemia CARE based on its last reported financial year (April March 2012) Lifeblood: The Thrombosis Charity Lifeblood: The Thrombosis Charity aims to increase awareness of thrombosis among the public and health professionals and to raise research funds to improve patient care During 2012, Pfizer supported Lifeblood with the following: We made a donation to support Lifeblood s National Thrombosis Week campaign and associated thrombosis education activities for healthcare professionals and patients. The BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited) made a donation to support Lifeblood s National Thrombosis Week campaign and associated thrombosis education activities for healthcare professionals and patients. 10,000 1,250* Total: 11,250 As a guide this amount represents 7% of the total income of Lifeblood based on its last reported financial year (February 2011 January 2012). We paid for the delivery of Lifeblood s materials to the Royal College of Nursing Annual Conference (value 325). *Amounts shown are Pfizer s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases. Lymphoma Association The Lymphoma Association is a registered charity founded by patients in 1986 which works to ensure that anyone affected by lymphatic cancer has access to relevant, accurate and timely information and support. During 2012, Pfizer supported the Lymphoma Association with the following: We sponsored the Lymphoma Association s Nurse Study Day educational meeting. In exchange for this sponsorship, Pfizer received a display stand at the event and two delegate places. We sponsored the Lymphoma Association s National Patient Conference. In exchange for this sponsorship, Pfizer received two delegate places and the Pfizer logo appeared on the marketing materials for the event ,000

19 We made a donation towards the production of the Lymphoma Association s patient information materials. During 2012, Pfizer contracted the following services from the Lymphoma Association: A staff member took part in Pfizer s Global Haematology Patient Advisory Board meeting. No consultancy fee was payable, but Pfizer paid for the staff member to travel to the meeting and stay overnight in a hotel. o Flight (value - $7,745 ( 4,845.36)) o Transfers (value - $ ( )) o Hotel (value - $ ( )) Total: 1,750 As a guide this amount represents less than 1% of the total income of the Lymphoma Association based on its last reported financial year (January 2011 December 2011). Macmillan Cancer Support Macmillan Cancer Support improves the lives of people affected by cancer. The charity provides practical, medical and financial support and pushes for better cancer care. During 2012, Pfizer supported Macmillan with the following: We sponsored the annual Britain Against Cancer conference in December 2012 for the cancer patient community to come together with other stakeholders. Macmillan organises this conference as part of its role as the Secretariat to the All Party Parliamentary Group on Cancer, We received four reduced rate delegate places as part of our sponsorship. We sponsored the annual Britain Against Cancer conference, for which Macmillan is the Secretariat to the All Party Parliamentary Group on Cancer, in December This payment was delayed and paid in our 2011/2012 financial year. We made a donation after an Olympics challenge event for Pfizer colleagues. The winning team member chose Macmillan as the charity they would like to support and to whom they would like to donate their prize money. We paid for four delegates spaces for colleagues to attend Britain Against Cancer A staff member from Macmillan led a workshop group at Pfizer s Cancer Agenda meeting. At this meeting, representatives from across the cancer community determined priorities for reducing inequities and improving cancer care across all four nations in the UK. 6,740 6, * 500* Total: 14,190 As a guide this amount represents less than 1% of the total income of Macmillan Cancer Support based on its last reported financial year (January December 2011). *These payments were made in our financial year 2011/2012 but were mistakenly disclosed in 2010/2011. Meningitis Research Foundation Meningitis Research Foundation funds research to prevent meningitis and septicaemia, and to improve survival rates and outcomes. The charity carries out an information and educational programme for the public

20 and health professionals to reduce death and disability, and offers befriending support and membership of the charity to people affected. During 2012, Pfizer supported Meningitis Research Foundation with the following: We made a donation to support the organisation's two-yearly healthcare professional training seminar. We made a donation to support the development of patient videos for the Meningitis Research Foundation website. We made a donation to support the development and delivery of a Meningitis student awareness campaign. We made a donation to support the development and delivery of a the Meningitis Matters Parliamentary Day. 2,000 8,000 5,000 8,000 During 2011, Pfizer contracted the following services from Meningitis Research Foundation: We paid a consultancy fee for the participation of an MRF staff member in an expert advisory committee on adolescent vaccination. Pfizer arranged and paid travel expenses for the staff member to travel to Washington, USA, to take place in the above advisory committee: o Flights (value - (US $7086) 4,653) o Accommodation (value - (US$554) 363) o Other (value - (US$463) 304) 2,787 0 Total: 25,787 As a guide this amount represents 1% of the total income of the Meningitis Research Foundation based on its last reported financial year (April 2011 March 2012). One delegate space on Pfizer thinkspace, a series of free development workshops open to the UK patient organisation community (estimated value 450). Meningitis Trust The Meningitis Trust provides ongoing practical and emotional support to families and individuals through a unique range of free services, including a 24-hour nurse helpline, financial support grants, counselling, art therapy, home visits, family days and community support. It is committed to raising awareness of meningitis and produces and distributes millions of leaflets, posters and symptoms cards every year. During 2012, Pfizer supported the Meningitis Trust with the following: We made a donation in support of the organisation's Winter Awareness campaign. We made a donation to support the organisation s work on adolescent meningitis. We made a donation to add to a colleague donation as part of our matched funding programme. We made a donation to allow staff members of the Meningitis Trust to attend the Meningitis Research Foundation s conference. 5,000 5, ,940 Total: 14,090 As a guide this amount represents less than 1% of the total income of the Meningitis Trust based on its last reported financial year (October October 2012).